Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss. 2012

Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
Service of Endocrinology, Diabetes and Metabolism, University Hospital CHUV, Lausanne, Switzerland.

OBJECTIVE To analyze the expression of peroxisome proliferator-activated receptor-γ1 and 2 (PPARγ1 and 2), 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1), and leptin in adipose tissue (AT) of obese women during weight loss following Roux-en-Y gastric bypass (RYGB) and to compare these levels with those obtained in AT of nonobese subjects. METHODS Gene expression was determined by real-time RT-PCR prior to surgery and at 3, 6, and 12 months after RYGB. RESULTS All obese patients lost weight, reaching a mean BMI of 29.3 ± 1.0 kg/m(2) at 1 year after surgery (-33.9 ± 1.5% of their initial body weight). In obese subjects leptin and 11βHSD1 were over-expressed, whereas PPARγ1 was expressed at lower levels compared to controls. After surgery, leptin and 11βHSD1 gene expression decreased, whereas PPARγ1 expression increased. At 12 months after RYGB, these 3 genes had reached levels similar to the controls. In contrast, PPARγ2 gene expression was not different between groups and types of tissue and remained unchanged during weight loss. We found a positive correlation between BMI and levels of gene expression of leptin and 11βHSD1. CONCLUSIONS Gene expression of leptin, PPARγ1, and 11βHSD1 in AT is modified in human obesity. This default is completely corrected by RYGB.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D009767 Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015390 Gastric Bypass Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption. Gastroileal Bypass,Gastrojejunostomy,Greenville Gastric Bypass,Roux-en-Y Gastric Bypass,Bypass, Gastric,Bypass, Gastroileal,Bypass, Roux-en-Y Gastric,Gastric Bypass, Greenville,Gastric Bypass, Roux-en-Y,Gastrojejunostomies,Roux en Y Gastric Bypass
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D043205 11-beta-Hydroxysteroid Dehydrogenase Type 1 A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors. 11 beta-Hydroxysteroid Dehydrogenase Type 1,11beta-HSD1,11beta-HSD1 Reductase,11beta-Hydroxysteroid Dehydrogenase Type 1,11beta HSD1 Reductase,11beta Hydroxysteroid Dehydrogenase Type 1

Related Publications

Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
January 2010, Journal of nutrigenetics and nutrigenomics,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
January 2010, World review of nutrition and dietetics,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
October 2015, Scientific reports,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
August 2016, International journal of obesity (2005),
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
July 2012, The American journal of clinical nutrition,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
February 2020, Endocrine connections,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
January 2023, PeerJ,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
February 2017, BMC genomics,
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
June 2016, International journal of obesity (2005),
Céline Leyvraz, and Chantal Verdumo, and Michel Suter, and Alexandre Paroz, and Jean-Marie Calmes, and Pedro M Marques-Vidal, and Vittorio Giusti
March 2013, Cancer prevention research (Philadelphia, Pa.),
Copied contents to your clipboard!